XML 42 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
4. Intangible Assets, Goodwill and Other (Tables)
12 Months Ended
Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes to goodwill by segment

Changes to goodwill by segment were as follows (in millions):
 
 
2015
 
 
2014
 
 
Life
Science
 
Clinical
Diagnostics
 
Total
 
 
Life
Science
 
Clinical
Diagnostics
 
Total
Balances as of January 1:
 
 
 
 
 
 
 
 
 
 
 
 
 
Goodwill
 
$
207.7

 
$
320.9

 
$
528.6

 
 
$
209.0

 
$
337.0

 
$
546.0

Accumulated impairment losses and write-offs
 
(27.2
)
 
(1.0
)
 
(28.2
)
 
 
(27.2
)
 
(1.0
)
 
(28.2
)
Goodwill, net
 
180.5

 
319.9

 
500.4

 
 
181.8

 
336.0

 
517.8

Acquisitions
 

 

 

 
 

 
13.5

 
13.5

Currency fluctuations
 
(0.5
)
 
(4.0
)
 
(4.5
)
 
 
(1.3
)
 
(29.6
)
 
(30.9
)
Balances as of December 31:
 
 
 
 
 
 
 
 
 
 
 
 
 
Goodwill
 
207.2

 
316.9

 
524.1

 
 
207.7

 
320.9

 
528.6

Accumulated impairment losses and write-offs
 
(27.2
)
 
(1.0
)
 
(28.2
)
 
 
(27.2
)
 
(1.0
)
 
(28.2
)
Goodwill, net
 
$
180.0

 
$
315.9

 
$
495.9

 
 
$
180.5

 
$
319.9

 
$
500.4

Schedule of Finite-Lived Intangible Assets by Major-Class
Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):
 
December 31, 2015
 
Average
Remaining
Life (years)
 
Purchase
Price
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships/lists
2-10
 
$
84.7

 
$
(46.8
)
 
$
37.9

Know how
1-10
 
184.0

 
(121.6
)
 
62.4

Developed product technology
4-12
 
101.3

 
(48.9
)
 
52.4

Licenses
3-10
 
39.2

 
(28.5
)
 
10.7

Tradenames
5-9
 
3.5

 
(2.4
)
 
1.1

Covenants not to compete
3-7
 
4.8

 
(1.7
)
 
3.1

     Total definite-lived intangible assets
 
 
417.5

 
(249.9
)
 
167.6

In-process research and development
 
 
46.4

 

 
46.4

     Total purchased intangible assets
 
 
$
463.9

 
$
(249.9
)
 
$
214.0


 
December 31, 2014
 
Average
Remaining
Life (years)
 
Purchase
Price
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships/lists
3-10
 
$
89.4

 
$
(43.0
)
 
$
46.4

Know how
1-11
 
184.7

 
(102.5
)
 
82.2

Developed product technology
5-12
 
103.9

 
(42.8
)
 
61.1

Licenses
1-11
 
39.4

 
(26.5
)
 
12.9

Tradenames
1-10
 
3.6

 
(2.1
)
 
1.5

Covenants not to compete
3-8
 
4.9

 
(1.2
)
 
3.7

     Total definite-lived intangible assets
 
 
425.9

 
(218.1
)
 
207.8

In-process research and development
 
 
46.4

 

 
46.4

     Total purchased intangible assets
 
 
$
472.3

 
$
(218.1
)
 
$
254.2